1. Home
  2. USA vs HRMY Comparison

USA vs HRMY Comparison

Compare USA & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty All-Star Equity Fund

USA

Liberty All-Star Equity Fund

SELL

Current Price

$5.68

Market Cap

1.8B

Sector

Finance

ML Signal

SELL

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

SELL

Current Price

$33.02

Market Cap

2.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
USA
HRMY
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.2B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
USA
HRMY
Price
$5.68
$33.02
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
★ $48.08
AVG Volume (30 Days)
★ 1.3M
1.1M
Earning Date
01-01-0001
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 7.97
EPS
N/A
★ 2.63
Revenue
N/A
★ $868,453,000.00
Revenue This Year
N/A
$18.31
Revenue Next Year
N/A
$14.97
P/E Ratio
★ N/A
$12.54
Revenue Growth
N/A
★ 21.51
52 Week Low
$5.40
$25.90
52 Week High
$6.43
$43.49

Technical Indicators

Market Signals
Indicator
USA
HRMY
Relative Strength Index (RSI) 35.32 32.48
Support Level $5.40 $32.53
Resistance Level $5.93 $33.00
Average True Range (ATR) 0.09 1.50
MACD -0.03 -0.19
Stochastic Oscillator 1.00 5.63

Price Performance

Historical Comparison
USA
HRMY

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a diversified, closed-end management investment company. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: